Ftse Mib
36.083,41
0,64%
DAX
21.411,53
0,72%
S&P 500
6.092,43
0,10%
NASDAQ
19.946,47
-0,31%
Bitcoin
105.501,91
1,80%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IDEXX Laboratories Inc (IDXX) IDEXX Laboratories Inc (IDXX) Notizie

IDEXX Laboratories Inc

IDXX
433,07
2,48 (0,58%)
Ultimo aggiornamento: 18:27:59
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202523:00EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16/1/202522:15BWIDEXX Laboratories to Release 2024 Fourth Quarter and Full..
19/12/202416:09GLOBESR Inc Announces 2024 SBER Awards: Top Honors Go to..
12/12/202422:00EDGAR2Form 8-K - Current report
09/12/202413:32EDGAR2Form 8-K - Current report
09/12/202413:30BWIDEXX Laboratories Announces Increase in Share Repurchase..
29/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:36EDGAR2Form 144 - Report of proposed sale of securities
21/11/202413:32EDGAR2Form 8-K - Current report
21/11/202413:30BWIDEXX Announces CFO Transition
12/11/202413:30EDGAR2Form 8-K - Current report
06/11/202422:00EDGAR2Form 8-K - Current report
31/10/202421:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202418:23EDGAR2Form 8-K/A - Current report: [Amend]
31/10/202418:15BWCORRECTING and REPLACING IDEXX Laboratories Announces Third..
31/10/202411:30EDGAR2Form 8-K - Current report
31/10/202411:30BWIDEXX Laboratories Announces Third Quarter Results
30/9/202420:00BWIDEXX Laboratories to Release 2024 Third Quarter Financial..
09/9/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:36EDGAR2Form 144 - Report of proposed sale of securities
05/9/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:15BWIDEXX Laboratories to Present at Morgan Stanley 22nd Annual..
07/8/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202412:30EDGAR2Form 8-K - Current report
06/8/202412:30BWIDEXX Laboratories Announces Second Quarter Results
30/7/202423:53BWIDEXX Laboratories Announces Time Change for 2024 Second..
30/7/202413:00PRNUSIDEXX Releases 2023 Corporate Responsibility Report,..
24/6/202417:00BWIDEXX Laboratories to Release 2024 Second Quarter Financial..
04/6/202413:00PRNUSIDEXX Expands Test Menu for the Catalyst Platform to Support..
31/5/202422:00EDGAR2Form SD - Specialized disclosure report
20/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202421:49EDGAR2Form 144 - Report of proposed sale of securities
14/5/202420:00BWIDEXX Laboratories to Present at Stifel Conference and..
10/5/202422:00EDGAR2Form 8-K - Current report
09/5/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202412:30BWIDEXX Laboratories Announces First Quarter Results
04/4/202422:30BWIDEXX Laboratories to Release 2024 First Quarter Financial..
07/3/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 429,49 Min: 426,11 Max: 434,56
Chiusura: 430,59

La tua Cronologia

NASDAQ
IDXX
IDEXX Laboratories
BIT
Z16273
Credit Suisse
BIT
UB8KNK
Unicredit Bank
BIT
F34737
Vontobel Financial Produ...
BIT
F38344
Vontobel Financial Produ...
BIT
F23296
Vontobel Financial Produ...
BIT
F24478
Vontobel Financial Produ...
BIT
F34757
Vontobel Financial Produ...
BIT
UB9LM2
Unicredit Bank
BIT
UC6MQH
Unicredit Bank
BIT
F23185
Vontobel Financial Produ...
BIT
FOHW
Franklin Future of Healt...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network